We are live on ! Find out more
PAVMZ

PAVmed Inc. Series Z Warrant

Delisted

PAVMZ was delisted on the 30th of April, 2025.

8 hedge funds and large institutions have $5.07M invested in PAVmed Inc. Series Z Warrant in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

161% more capital invested

Capital invested by funds: $1.94M → $5.07M (+$3.13M)

11% less funds holding

Funds holding: 98 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
8
Holders Change
-1
Holders Change %
-11.11%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
WAM
1
Warberg Asset Management
Illinois
$3.1M +$1.82M +337,390 +311%
WAM
2
Wolverine Asset Management
Illinois
$1.36M +$191K +35,424 +22%
LCS
3
Levin Capital Strategies
New York
$433K +$139K +25,800 +70%
VF
4
Virtu Financial
New York
$151K +$118K +21,808 New
UBS Group
5
UBS Group
Switzerland
$21K -$14.9K -2,757 -47%
Bank of America
6
Bank of America
North Carolina
$7K
PNC Financial Services Group
7
PNC Financial Services Group
Pennsylvania
$7K +$5.39K +1,000 New
Morgan Stanley
8
Morgan Stanley
New York
$1K
ICM
9
Ionic Capital Management
New York
-$374K -77,066 Closed
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
-$52K -10,875 Closed
TWA
11
TCI Wealth Advisors
Arizona
-$3K -700 Closed

PAVMZ Hedge Fund Activity: Q3 2021 in Review

8 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q3 2021, worth a combined $5.07M — up 161% from $1.94M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of PAVMZ and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.

The largest buyer was Warberg Asset Management, adding an estimated $1.82M. The largest seller was Ionic Capital Management, exiting entirely with an estimated $374K sold.

  • 8 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q3 2021, down from 9 in Q2 2021.
  • Funds reported $5.07M of PAVmed Inc. Series Z Warrant stock for Q3 2021, up 161% quarter-over-quarter.
  • 2 funds opened new PAVmed Inc. Series Z Warrant positions in Q3 2021 and 3 closed out, a net change of -1 holder.
  • The largest PAVmed Inc. Series Z Warrant buyer in Q3 2021 was Warberg Asset Management, an estimated $1.82M added.
  • The largest PAVmed Inc. Series Z Warrant seller in Q3 2021 was Ionic Capital Management, an estimated $374K sold.

Based on aggregated 13F filings for Q3 2021.